Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03063775
Other study ID # 7333
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date January 9, 2017
Est. completion date November 8, 2018

Study information

Verified date May 2019
Source Medical University of Graz
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is planned to evaluate if a porcine collagen matrix (Mucograft Seal) is offering comparable results to free gingival grafts (FGG) in post-extraction tissue preservation. If so, this would provide a substantial benefit to the patient as the second intervention on the palate and the subsequent morbidity of the donor site is omitted.


Description:

In a proof of concept 5 groups are compared in preserving soft- and hard tissue after tooth extraction in the esthetic zone:

1. Mucograft® Seal + Bio-Oss®

2. Free Gingival Graft (FGG) + Bio-Oss®

3. Free Gingival Graft + Gelatine sponge (Spongostan®)

4. Spongostan®+ Mucograft® Seal

5. Spongostan®

Volumetric changes of hard and soft tissues are recorded , 2/4/8 weeks and 3/6/12 months after extraction.


Recruitment information / eligibility

Status Terminated
Enrollment 1
Est. completion date November 8, 2018
Est. primary completion date November 8, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

• Planned extraction in the upper front or premolar region

Exclusion Criteria:

- General risk situation (antiresorptive therapy, antiangiogenic therapy, history of local radiation therapy, heavy coagulation disorder, relevant allergies, dysregulated Diabetes mellitus, malignant diseases)

- Acute gingivitis

- Deep pockets (>5.5mm)

- Apical periodontitis on neighboring teeth

- Heavy smoker (>10/d)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
BioOss® + Mucograft Seal®
Placement of BioOss®-Collagen into the extraction socket. The Mucograft Seal® Membrane is then applied to the socket.
Other:
FGG + Bio-Oss®
Placement of BioOss®-Collagen into the extraction socket. The FGG is then attached to the socket.
FGG + Gelatine sponge (Spongostan®)
Placement of a Gelatine sponge into the extraction socket, then attaching the FGG to the socket.
Device:
Spongostan®+ Mucograft® Seal
Placement of a Gelatine sponge into the extraction socket, then attaching the Mucograft® Seal Membrane to the socket

Locations

Country Name City State
Austria Medical University Graz Graz Styria

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Graz

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Soft tissue volume 2 weeks
Primary Soft tissue volume 4 weeks
Primary Soft tissue volume 8 weeks
Secondary Bone volume 3 months
Secondary Bone volume 6 months
Secondary Bone volume 12 months